Breaking News
Palantir Manifesto Shows The Clear Convergence Of Technofascism With Technocracy
Washington's Democrat ex-governor says she's disgusted at millionaires' tax...
The Odyssey Backlash Goes NUCLEAR - WTF Nolan?
He Got Banned From Selling Skateboards | Joe Rogan
Top Tech News
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...
Cameco Sees As Many As 20 AP1000 Nuclear Reactors On The Horizon
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Mayo Clinic's AI Can Detect Pancreatic Cancer up to 3 Years Before Diagnosis–When Treatment...
A multi-terrain robot from China is going viral, not because of raw speed or power...
The World's Biggest Fusion Reactor Just Hit A Milestone
Wow. Researchers just built an AI that can control your body...
Google Chrome silently installs a 4 GB AI model on your device without consent
The $5 Battery That Never Dies - Edison Buried This 100 Years Ago
Longeveron developing stem cell treatments for Frailty, Alzheimers and other aging diseases
Longeveron is a privately funded startup. The Longeveron-grown Mesenchymal Stem Cells (LMSCs) are multipotent stem cells.
Mesenchymal stem cells, or MSCs, are multipotent stromal cells that can differentiate into a variety of cell types, including: osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells) and adipocytes (fat cells which give rise to marrow adipose tissue). MSC have been found in organisms (in-vivo) and have been studied as well in tissue culture (in-vitro).
Nextbigfuture interviewed Dr. Joshua Hare, Longeveron Chief Science Officer. Dr. Joshua Hare co-founded Longeveron in 2014 utilizing intellectual property and technology exclusively licensed from the University of Miami, where he is also the founding Director of the university's Interdisciplinary Stem Cell Institute (ISCI).